SAB Biotherapeutics Statistics
NASDAQ: SABSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.88-0.05 (-1.71%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
SAB Biotherapeutics by the numbers
SAB Biotherapeutics has a market capitalization of $262.0 million based on 90.99M shares outstanding. With trailing EPS of $-1.29, SAB Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.2% below its 50-day average and 23.5% below its 200-day average.
Average daily trading volume is 486.82K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SABS valuation vs. peer median
| Metric | SABS | Peer median | Difference |
|---|---|---|---|
| Market cap | $262.04M | $264.31M | -1% |
| Avg. volume | 486.82K | 998.77K | -51% |
Peer median across 8 companies: IKT, LXEO, PALI, FATE, XFOR, STRO, LCTX, SRZN.
Valuation
- Market cap
- $262.04M
- EPS (TTM)
- $-1.29
- Shares outstanding
- 90.99M
Price and trading
- Previous close
- 2.93
- Open
- 2.90
- Day range
- 2.81 – 2.96
- 52-week range
- 2.10 – 5.15
- 52-week change
- +23.08%
- Beta
- —
- Volume
- 679.31K
- Average volume
- 486.82K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 262.04M
- Forward Pe
- -3.02
- Eps
- -1.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.15
- Week52 Low
- 2.10
- Avg Volume
- 486.82K
- Shares Outstanding
- 90.99M
- Ma50
- 3.57
- Ma200
- 3.77
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -44.08%
- Pct From52w Low
- 37.14%